<VariationArchive VariationID="2674634" VariationName="NM_006567.5:c.(?_-4)_(612+185_613-1)del" VariationType="Deletion" Accession="VCV002674634" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-14" DateCreated="2023-12-30" MostRecentSubmission="2023-12-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2842120" VariationID="2674634">
      <GeneList>
        <Gene Symbol="FARS2" FullName="phenylalanyl-tRNA synthetase 2, mitochondrial" GeneID="10667" HGNC_ID="HGNC:21062" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>6p25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="5249934" stop="5771583" display_start="5249934" display_stop="5771583" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="5261583" stop="5771815" display_start="5261583" display_stop="5771815" Strand="+" />
          </Location>
          <OMIM>611592</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006567.5:c.(?_-4)_(612+185_613-1)del</Name>
      <VariantType>Deletion</VariantType>
      <OtherNameList>
        <Name>EX2DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006567.5" sequenceAccession="NM_006567" sequenceVersion="5" change="c.(?_-4)_(612+185_613–1)del" MANESelect="true">
            <Expression>NM_006567.5:c.(?_-4)_(612+185_613–1)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006567.5" sequenceAccession="NM_006567" sequenceVersion="5" change="c.(?_-4)_(612+185_613-1)del" MANESelect="true">
            <Expression>NM_006567.5:c.(?_-4)_(612+185_613-1)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="611592.0011" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006567.5:c.(?_-4)_(612+185_613-1)del AND Combined oxidative phosphorylation defect type 14" Accession="RCV003459880" Version="1">
        <ClassifiedConditionList TraitSetID="9027">
          <ClassifiedCondition DB="MedGen" ID="C4755312">Combined oxidative phosphorylation defect type 14</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-12-30" MostRecentSubmission="2023-12-30">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">37523899</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9027" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17497" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Combined oxidative phosphorylation defect type 14</ElementValue>
                <XRef ID="MONDO:0013986" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Combined oxidative phosphorylation deficiency 14</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">COXPD14</ElementValue>
                <XRef Type="MIM" ID="614946" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17455" />
                <XRef ID="17455" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of FARS2 deficiency ranges from the infantile-onset phenotype, characterized by epileptic encephalopathy with lactic acidosis and poor prognosis (70% of affected individuals), to the later-onset phenotype, characterized by spastic paraplegia, less severe neurologic manifestations, and longer survival (30% of affected individuals). To date FARS2 deficiency has been reported in 37 individuals from 25 families. Infantile-onset phenotype. Seizures are difficult to control and may progress quickly at an early age to intractable seizures with frequent status epilepticus; some children have hypsarrhythmia on EEG. All have developmental delay; most are nonverbal and unable to walk. Feeding difficulties are common. More than half of affected children die in early childhood. Later-onset phenotype. All affected individuals have spastic paraplegia manifested by weakness, spasticity, and exaggerated reflexes of the lower extremities associated with walking difficulties; some have developmental delay/intellectual disability; some have brief seizures that resolve over time.</Attribute>
                <XRef ID="NBK538658" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30869852</ID>
                <ID Source="BookShelf">NBK538658</ID>
              </Citation>
              <XRef ID="319519" DB="Orphanet" />
              <XRef ID="C4755312" DB="MedGen" />
              <XRef ID="MONDO:0013986" DB="MONDO" />
              <XRef Type="MIM" ID="614946" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7840017" SubmissionDate="2023-12-21" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="611592.0011_COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14" title="FARS2, EX2DEL_COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14" />
        <ClinVarAccession Accession="SCV004190189" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a male infant with combined oxidative phosphorylation deficiency-14 (COXPD14; 614946), Chen et al. (2023) identified compound heterozygous mutations in the FARS2 gene: a deletion of exon 2 (NM_006567.5), the first coding exon, and a c.593G-T transversion, resulting in an arg198-to-leu (R198L; 611592.0012) substitution. The mutations were identified by trio whole-exome sequencing, and the parents were shown to be mutation carriers. The R198L mutation was present in the gnomAD database in 1 of 125,000 alleles and was not present in homozygosity. Steady state levels of mtPheRS were reduced in patient fibroblasts.</Attribute>
              <Citation>
                <ID Source="PubMed">37523899</ID>
              </Citation>
              <XRef DB="OMIM" ID="614946" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FARS2" />
          </GeneList>
          <Name>FARS2, EX2DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX2DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611592.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7840017" TraitType="Disease" MappingType="Name" MappingValue="COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14" MappingRef="Preferred">
        <MedGen CUI="C4755312" Name="Combined oxidative phosphorylation defect type 14" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

